Summit Therapeutics' latest HARMONi trial data shows PFS benefit, but overall survival improvement remains unclear. Click ...

The detailed results from the HARMONi trial—the first global phase 3 data set for the world’s first PD-1xVEGF bispecific, ...

The cybersecurity sector is obsessed with measuring risk. We track CVEs, count patches, and calculate compliance scores. And ...

Everyone who has ever lived on Earth has been well-aware of the moon, but it turns out Earth also has some frequent temporary ...

That sinking feeling when the “Check Engine” light pops on is universal, isn’t it? It’s not just the fear of a hefty bill; it ...

For adults with a history of smoking undergoing low-dose computed tomography (LDCT) for lung cancer screening, emphysema is ...

Revolution Medicines, Inc. shares surged on strong Phase 1 data for daraxonrasib in metastatic pancreatic cancer. Click here ...

Two new real-world studies estimate the effectiveness of a single dose of a respiratory syncytial virus (RSV) vaccine against ...

A minimally invasive procedure with medical management was nonsuperior to medical management alone at 180 days in a cohort of ...

During a live event, Neil M. Iyengar, MD, discusses NCCN guidelines and NATALEE trial data for using CDK4/6 inhibitors like ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

MADRID, Spain—Stopping oral anticoagulation (OAC) improves outcomes among patients who remain free from atrial arrhythmia ...